Skip to main content

Ravi Patel, MD, PhD

  • Assistant Professor, University of Pittsburgh Department of Radiation Oncology
  • Director of Radiopharmaceuticals, UPMC Hillman Cancer Center

Ravi Patel, MD, is an assistant professor at the UPMC Hillman Cancer Center specializing in the study and treatment of skin, breast, and genitourinary malignancies. His research focuses on utilizing radiation therapy to immunomodulate the tumor microenvironment to enhance the efficacy of immunotherapy treatments in solid tumors. He provides expertise in radiopharmaceutical therapy and radiopharmaceutical dosimetry.

    Education & Training

  • MS: Case Western Reserve University, 2008
  • PhD: Biomedical Engineering, Case Western Reserve University, 2011
  • MD: Case Western Reserve University, 2012
  • Residency: Radiation Oncology, University Hospitals of Cleveland, 2020
Awards
Hillman Emerging Scholar Award, 2024, 2023, 2022
Forbeck Fellow RRS Annual Meeting, ECI Travel Award, 2021
Hillman Clinical Translational Junior Scholar Award, Hillman Cancer Center, 2020
Hillman Early Career Fellow for Innovative Cancer Research, Hillman Cancer Center, 2019
Winter School Travel Award, Society of Immunotherapy in Cancer, 2019
Representative Publications

PubMed® Link: Ravi Patel, MD, PhD

Research Grants

R01CA275766
Patel (PI)
07/01/23-06/30/28
Integrating VLA-4–targeted 67Cu-LLP2A radiotherapy to improve T-cell based adoptive immunotherapy.

K08 CA241319
Patel (PI)
07/01/19-06/30/24
Utilization of molecular targeted radioisotopes to prime immune responses at local and distant metastatic tumor sites.